Prostate cancer ranks 5th in cancer mortality with 8950 deaths per year (FRANCIM data).
For localized cancers, conventional radical treatments of the entire gland (surgery, radiotherapy) are accompanied by severe sequelae which alter the quality of life of the patients and there is a need to develop less morbid treatments.
As such, focal therapy, which treats only the cancerous area of the gland in a targeted way, appears as a promising alternative and would minimize urinary and sexual sequelae.
However, the traditional diagnostic strategy based on transrectal "biopsies" with ultrasound guidance is a brake because it is accompanied by many diagnostic imprecisions
In fact, the planning and the realization of a focal therapy require precise and reliable localization of the tumor target within the gland.
Full article on the website "professional health platform"